ATE171463T1 - Ester aus pektin und pektinische saure - Google Patents

Ester aus pektin und pektinische saure

Info

Publication number
ATE171463T1
ATE171463T1 AT93902199T AT93902199T ATE171463T1 AT E171463 T1 ATE171463 T1 AT E171463T1 AT 93902199 T AT93902199 T AT 93902199T AT 93902199 T AT93902199 T AT 93902199T AT E171463 T1 ATE171463 T1 AT E171463T1
Authority
AT
Austria
Prior art keywords
acid
esters
pectinic acid
pectine
pectinic
Prior art date
Application number
AT93902199T
Other languages
English (en)
Inventor
Vittorio Crescenzi
Lanfranco Callegaro
Original Assignee
Murst Italian
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=11389767&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE171463(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Murst Italian filed Critical Murst Italian
Application granted granted Critical
Publication of ATE171463T1 publication Critical patent/ATE171463T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L29/00Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/20Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents
    • A23L29/206Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of vegetable origin
    • A23L29/231Pectin; Derivatives thereof
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B82NANOTECHNOLOGY
    • B82YSPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/61Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6949Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
    • A61K47/6951Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/02Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/0241Containing particulates characterized by their shape and/or structure
    • A61K8/025Explicitly spheroidal or spherical shape
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73Polysaccharides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1629Organic macromolecular compounds
    • A61K9/1652Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08BPOLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0045Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid alpha-D-Galacturonans, e.g. methyl ester of (alpha-1,4)-linked D-galacturonic acid units, i.e. pectin, or hydrolysis product of methyl ester of alpha-1,4-linked D-galacturonic acid units, i.e. pectinic acid; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Birds (AREA)
  • Polymers & Plastics (AREA)
  • Nanotechnology (AREA)
  • Molecular Biology (AREA)
  • Nutrition Science (AREA)
  • Inorganic Chemistry (AREA)
  • Biophysics (AREA)
  • Medical Informatics (AREA)
  • Food Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Dispersion Chemistry (AREA)
  • Biotechnology (AREA)
  • Dermatology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Biochemistry (AREA)
  • Materials Engineering (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Cosmetics (AREA)
  • Medicinal Preparation (AREA)
AT93902199T 1992-01-13 1993-01-12 Ester aus pektin und pektinische saure ATE171463T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITPD920004A IT1264321B (it) 1992-01-13 1992-01-13 Esteri di acidi pectici e pectinici, procedimento di preparazione e loro applicazioni farmaceutiche e biosanitarie

Publications (1)

Publication Number Publication Date
ATE171463T1 true ATE171463T1 (de) 1998-10-15

Family

ID=11389767

Family Applications (1)

Application Number Title Priority Date Filing Date
AT93902199T ATE171463T1 (de) 1992-01-13 1993-01-12 Ester aus pektin und pektinische saure

Country Status (8)

Country Link
US (1) US5384400A (de)
EP (1) EP0621877B2 (de)
JP (1) JP3717924B2 (de)
AT (1) ATE171463T1 (de)
AU (1) AU4264193A (de)
DE (1) DE69321215T3 (de)
IT (1) IT1264321B (de)
WO (1) WO1993014129A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995000158A1 (en) * 1993-06-25 1995-01-05 Bio-Sphere Technology Dietary supplement incorporating beta-sitosterol and pectin
IT1263394B (it) * 1993-07-30 1996-08-05 Fidia Advanced Biopolymers Srl Composizioni farmaceutiche per uso topico a base di acido ialuronico e suoi derivati
PL182804B1 (pl) * 1995-02-07 2002-03-29 Fidia Advanced Biopolymers Sposób powlekania powierzchni przedmiotu kwasem hialuronowym lub pochodną kwasu hialuronowego i sposób powlekania powierzchni przedmiotu polimerem półsyntetycznym
PE20060468A1 (es) * 2004-04-26 2006-07-06 Cp Kelco Aps Composicion dermoprotectora para controlar la alcalinidad de la piel que comprende polisacaridos de acido carboxilico
US20070092622A1 (en) * 2005-10-25 2007-04-26 Trudsoe Jens E Composition containing pectin ester
US20070098870A1 (en) * 2005-10-27 2007-05-03 Trudsoe Jens E Composition containing alkylene oxide derivative of pectin
US9815912B2 (en) * 2012-03-19 2017-11-14 University Of Massachusetts Hydrophilic modification of water insoluble polysaccharide as surface-active agents
EP2938348A4 (de) * 2012-12-30 2016-07-27 Hadasit Med Res Service Alginatezusammensetzungen und verwendungen davon
KR20210045453A (ko) * 2018-08-17 2021-04-26 세페이드 핵산 오염 제거 방법

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL63942C (de) *
US2960498A (en) * 1956-04-02 1960-11-15 Burke Oliver W Jun Partial glycerol esters of pectic substances and preparation thereof
US3326760A (en) * 1966-05-17 1967-06-20 Synergistics Inc Choline salicylate polygalacturonate therapy
JPS4939192A (de) * 1972-08-18 1974-04-12
JPS5023671A (de) * 1973-07-02 1975-03-13
SU584012A1 (ru) * 1976-02-05 1977-12-15 Институт органической химии АН Киргизской ССР Способ получени пектата глицерина
JPS58186491A (ja) * 1982-04-19 1983-10-31 Hayashibara Biochem Lab Inc ミカン缶詰廃液の処理方法及びミカン缶詰廃液からペクチン質を製造する方法
US5008254A (en) * 1982-09-03 1991-04-16 Weibel Michael K Sugar beet pectins and their use in comestibles
US5071970A (en) * 1988-11-23 1991-12-10 University Of Florida Process for producing pectin with a high-to-medium methoxyl content from beet pulp

Also Published As

Publication number Publication date
IT1264321B (it) 1996-09-23
EP0621877B1 (de) 1998-09-23
DE69321215T3 (de) 2002-12-12
DE69321215D1 (de) 1998-10-29
AU4264193A (en) 1993-08-03
ITPD920004A1 (it) 1993-07-14
US5384400A (en) 1995-01-24
JPH07508542A (ja) 1995-09-21
EP0621877A1 (de) 1994-11-02
DE69321215T2 (de) 1999-06-02
EP0621877B2 (de) 2002-04-24
JP3717924B2 (ja) 2005-11-16
ITPD920004A0 (it) 1992-01-13
WO1993014129A1 (en) 1993-07-22

Similar Documents

Publication Publication Date Title
KR960702768A (ko) 촉매 조성물 및 카복실산 에스테르의 수소화에서의 이들의 용도(catalyst compositions and the use thereof in the hydrogenation of carboxylic acid esters)
ES2001512A6 (es) Procedimiento para la fabricacion de esteres totales y parciales del acido hialuronico
ATE288270T1 (de) Mikroverkapselte 1,2-benzazole
ATE171463T1 (de) Ester aus pektin und pektinische saure
ES2082507T5 (es) Composiciones de aerosol presurizado.
DE69506493D1 (de) Herstellung von Difluoressigsäurefluoride und von Ester der Difluoressigsäure
NO894888D0 (no) Esterfremstilling ved hydrogenering av karboksylsyre og anhydrider.
ITPD940043A0 (it) "esteri attivi di polisaccaridi carbossilici"
ATE138639T1 (de) L-carnitin- und alkanoyl-l-carnitin-ester mit glykolsäure oder ihre ester und diese enthaltende pharmazeutische zusammensetzungen zur behandlung von dermatosen
NO175307C (no) Analogifremgangsmåte for fremstilling av nye terapeutisk aktive 3,3'-ditiobis(propionsyrer)
DE59308469D1 (de) Fluorierte Carbonsäureester von Phosphono- und Phosphinocarbonsäuren sowie deren Verwendung
BE1002024A6 (fr) Preparation medicamenteuse a base de derives d'esters d'hecogenine et leur utilisation pour le traitement de l'hyperplasie prostatique benigne.
ATE81770T1 (de) Haut- und haarpflegemittel.
YU184090A (sh) Stabilizovani interferoni leukocita
ATE345777T1 (de) Biologisch aktive zusammensetzung
ITMI930337A0 (it) Esteri di acidi carbossilici di idrossifenilelcanoli come agenti stabilizzanti
IT1076780B (it) Esteri benzilici ed esteri analoghi di acidi 6,11-diidrodibenz parentesi quadra aperta b,e parentesi quadra chiusa-ossepin-acetici
DE59010296D1 (de) Polyethercarbonsäureester und ihre Herstellung
IT1140789B (it) Esteri sostituiti dell'acido ciclopropancarbossilico e composizioni insetticide che contengono i medesimi come ingrediente attivo
JPS5626842A (en) Aliphatic acid ester of beta-thujaplicin and fair-skinning cosmetic having said ester as active component
KR940005264A (ko) 국소치료제
IT1066095B (it) Composizioni insetticide ed acaricide a base di esteri fenossibenzilici di acidi spirocarbossilici
DE69214999D1 (de) Polymer-Latice von Vinylacetat und Vinylester von verzweigter Karboxylsäure
SE9503799D0 (sv) Bio-degradable/absorbable barrier membrane
JPS55115857A (en) Manufacture of alpha*betaaunsaturated nnsubstituted carboxylic acid amide*said compound*polymer thereof and its use

Legal Events

Date Code Title Description
REN Ceased due to non-payment of the annual fee